
Glybloc 50mg Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Miglitol (50mg)
Overview Glybloc 50mg Tablet
Diabex 50mg tablets manage type 2 diabetes by regulating postprandial hyperglycemia. Prescribed when diet and other therapies prove insufficient, Diabex 50mg should be ingested immediately before or with the initial bite of a meal. Dosage and frequency are determined individually by your physician to optimize blood glucose control, potentially increasing incrementally. Discontinuing treatment without medical supervision risks elevated blood sugar and associated complications, such as nephropathy and visual impairment. This medication is one component of a comprehensive diabetes management plan encompassing diet, physical activity, and weight management, as directed by your doctor. Regular blood glucose monitoring is essential. Commonly reported side effects include skin eruptions, flatulence, abdominal discomfort, and bowel looseness; consult your physician if these persist or worsen. While Diabex 50mg itself doesn't induce hypoglycemia, concomitant use with other antidiabetic agents (particularly insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective. Inform your doctor of any hepatic or renal issues prior to commencing treatment. Individuals with inflammatory bowel conditions (e.g., ulcerative colitis, Crohn's disease) should avoid this medication. Pregnant or lactating women require medical consultation before use. Comprehensive disclosure of all other medications is crucial for safety. Limit alcohol consumption to minimize the hypoglycemic risk.
Primary Ingredients of Glybloc 50mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Glybloc 50mg Tablet
Managing type 2 diabetes
Major Benefits of Glybloc 50mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glybloc 50mg Tablet with a meal.
Common Side effects of Glybloc 50mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Glybloc 50mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 50mg Glybloc tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with a meal.
How Glybloc 50mg Tablet works:
Glybloc 50mg tablets are used to manage diabetes. They work by blocking the digestive enzymes that process complex carbohydrates, thus reducing post-meal spikes in blood sugar.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glybloc 50mg Tablet with alcohol is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Glybloc 50mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and Glybloc 50mg tablets appear compatible. Available human data indicates minimal infant risk associated with this medication.
DrivingSAFE
Driving ability is typically unaffected by Glybloc 50mg Tablets.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Glybloc 50mg tablets, potentially requiring dosage modification under medical supervision. Glybloc 50mg tablets are contraindicated for patients exhibiting severe kidney disease.
LiverSAFE IF PRESCRIBED
Glybloc 50mg tablets are likely safe for individuals with liver conditions. Existing evidence indicates dose modification may not be necessary. However, physician consultation is recommended.
What if you forget to take Glybloc 50mg Tablet :
Omit any missed Glybloc 50mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Glybloc 50mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Nojirimycin Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Alpha-glucosidase inhibitors |
